John K A Prendergast
CIK 1042019 · last filed 2026-08-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HTBX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
627 DAVIS DRIVE, SUITE 300
MORRISVILLE, NC 27560
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTN | Director | 15,102 | $4.93 | $74.5K | $0 | 22 | 2026-08-05 |
| Scorpius Holdings, Inc. (NHWK) Delisted | Director | — | $0.41 | — | $0 | 1 | 2022-12-09 |
| Scorpius Holdings, Inc. (HTBX) Delisted | Director | 203,272 | $2.38 | $483.8K | -$205.3K | 9 | 2022-01-03 |
| MNOV | Director | — | $1.41 | — | $0 | 6 | 2011-07-20 |
| AVIGEN INC \DE (AVGN) Delisted | Director | 40,845 | — | — | -$105.0K | 4 | 2008-08-15 |
Recent Filings · Page 2 of 5
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-06 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +138,272 | $0 | EDGAR |
| 2020-06-18 | PTN | Grant (A) | +99,000 | $0 | EDGAR |
| 2020-01-02 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +400,000 | $0 | EDGAR |
| 2019-06-26 | PTN | Grant (A) | +84,000 | $0 | EDGAR |
| 2019-01-03 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2018-06-28 | PTN | Grant (A) | +56,000 | $0 | EDGAR |
| 2018-01-10 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-13 | PTN | Grant (A) | +60,000 | $0 | EDGAR |
| 2017-06-22 | PTN | Grant (A) | +108,000 | $0 | EDGAR |
| 2017-01-04 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.